Biotechnology Development

 

Micropoint biotechnology R&D leverages strong collaboration with groups of researchers and scientists around the world to develop novel biomarkers and antibodies that are customized to meet the rapid diagnostic needs. These co-development programs encompass sets/libraries of bio-marker screening, cell line engineering, protein expression, and bio-processing.

 

Micropoint works with its partners to develop novel bio-markers and antibodies with high affinity and high specificity in each of the following stages:

 

  • Hybridoma development

  • Polyclonal antibody

  • Antibody purification

  • Antibody Fragmentation and isotyping

  • Conjugation and labeling

  • Immune response testing

  • Novel assay development

  • Bio-signal amplifications

     

 

 

U.S. Headquarters

 

Micropoint Bioscience, Inc.
3521 Leonard Court 
Santa Clara, CA 95054
United States

 

T:+1 (408) 588-1682
F:+1 (408) 588-1620

 

 

European Office

 

Micropoint Bioscience, Inc.

2 rue Eugene Sue

38100 Grenoble

France 

 

T: +33 6 22 38 20 48

F: +33 4 76 09 03 50

Asian Office

 

Micropoint Biotechnologies Co., Ltd.

5F, Bldg 1

Runheng Dingfeng Industrial Park, Liuxian 2 Rd.

Shenzhen 518101, Guangdong

China

 

T: +86 755 21600849

F: +86 755 86673903

Copyright Micropoint Biosciences 2016

Micropoint Bioscience products are not available for sale nor marketed in the United States at this time.